​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

​​
  • January 26, 2026 Prescription Drug Affordability Board Meeting CANCELEDDue to the declared state of emergency and the closing of State offices and facilities, the Prescription Drug Affordability Board meeting scheduled for Monday, January 26, 2026 is cancel​ed. When the meeting is rescheduled, the Board will provide advance notice of the rescheduled meeting date on the website and through the listserv.

  • Informational Hearing Notice: The Maryland Prescription Drug Affordability Board is evaluating its cost review study process (COMAR 14.01.04.01, et seq.) and policy review procedures (COMAR 14.01.05.01, et seq.), and invites public comment on these procedures. More information can be found here. These hearings will take place on February 10, 2026.
  • Join the PDAB Mailing List here​.​

Section2

Get Inv​olved​​​

​​​​

Section3

Section5